Publish fast. Openly. Without restrictions.

F1000Research believe that all valid research deserves publication irrespective of the perceived level of interest or novelty; we welcome confirmatory and negative results, as well as null studies.

F1000Research welcomes original research that:

• Reports scientific, scholarly, translational or clinical research
• Is within the disciplines of medicine and health or the life, earth and environmental sciences
• Adheres to our ethical and editorial policies
• Adheres to our Open Data policies
• Is authored by a researcher, scholar or clinician actively working in their specialty

Got questions about our Open Data Policy? We’ve got answers. Explore our brand new hub of resources for researchers, designed to help you understand the what, why, and how of data sharing for your submission to F1000Research.

For other questions about F1000Research please see our comprehensive FAQ section.

What types of research outputs do you publish?

F1000Research publishes a number of different research outputs, and welcomes confirmatory and negative results, as well as null studies. We currently publish Research Articles, Brief Reports, Data Notes, Case Reports, Clinical Practice Articles, Antibody Validation Articles, Software Tool Articles, Method Articles, Study Protocols, Registered Reports, Reviews, Systematic Reviews, Opinion Articles, Correspondence or Editorials.

Will the fact that my article has been rejected elsewhere impact my chances of being published on F1000Research?

No. Your article will be treated in the same way as every other article submitted and, as long as it passes our rigorous pre-publication checks and conforms to our ethical and editorial and Open Data policies, it will be published on F1000Research.

How long will it take for me to see my research appear on F1000Research?

You could see your work appear on the platform in as few as 14 days.

What is post-publication peer review, and why have you chosen this model?

The reason we conduct peer review after publication is to remove the delay in others being able to benefit from accessing the work during the reviewing period (similar to preprints). Closed (and sometimes biased) review processes can often take many months, sometimes even years, and may allow competing papers to be published first. The F1000Research model removes the possibility of a paper being deliberately blocked or held up by a single editor or reviewer, whilst enabling the reader to clearly see the level of review an article has gone through at each stage. It also allows other scientists in the field to judge the work for themselves and start building on it, perhaps repeat the analysis for themselves, while expert reviewers assess it.

Are there any costs associated with submitting to F1000Research after rejection from another Taylor and Francis journal?

F1000Research is an open access publication platform. This means we charge an article processing charge (APC) for all articles. APCs in F1000Research are based on article type. There are no additional costs for submitting a previously rejected article.

Where will my article be indexed?

Articles are immediately indexed in Google Scholar. Once an article passes peer review (i.e. it has received at least two Approved peer review reports, or one Approved plus two Approved with Reservations reviews), it will be indexed in PubMed, PubMed Central, MEDLINE, Europe PMC, Scopus, Chemical Abstracts Service, British Library, CrossRef, DOAJ, and Embase.

For other questions about F1000Research please see our comprehensive FAQ section.

Submit now

• Enables authors, not editors, to decide what they wish to publish.
• Authors suggest peer reviewers and control the process.
• All types of research can be published rapidly: traditional articles, data sets, null results, protocols, case reports, incremental findings and more.